Corporate Partnership Programme
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
EMBL boasts some of the best scientific talent in Europe. Get in touch.
The European Molecular Biology Laboratory employs some of the greatest minds in European science. Our talent pool boasts biologists, engineers, IT professionals and countless other scientific specialisations. In addition, EMBL research has many practical and industrial applications
We harness EMBL’s entrepreneurial spirit through technology transfer programmes and technology spin-offs.
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). Established in 1999, EMBLEM identifies, protects and commercialises the intellectual property developed at EMBL, by EMBL alumni and by non-EMBL third parties. EMBLEM works closely with industrial partners in the biotech, IT and engineering markets to accelerate the transfer of innovative technology from basic research to industry.
EMBLEM manages a portfolio of close to 300 individual patents, patent applications, copyrights, trademarks and utility models. The technology portfolio, which spans the life sciences, includes enabling technologies, scientific instruments, molecular tools and techniques, as well as software programmes and databases.
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
A forum for interaction and knowledge exchange for those employed at the forefront of industrial bioinformatics.
A freely-available, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
The Agri-Tech Partnership establishes collaboration with domain experts in advanced agricultural technologies from both public and private sectors.
Based in Heidelberg, Germany, EMBL Ventures invest throughout Europe to build companies that create significant commercial opportunities based on new therapeutic-treatment modalities and pharmaceuticals, next-generation enabling-technology platforms or innovations in the diagnostics and medical device area.
As an independent and focused team, EMBL Ventures moves quickly with short decision timelines.
Industry news from EMBL’s six sites
New ‘teaming’ projects in genomic medicine and wastewater monitoring will serve important research needs in Portugal and Latvia.
Edit
Members of the McCarthy Team at EMBL Grenoble talk about BSxCuBE-Web, a web-based interface to automate BioSAXS experiments, and how the ARISE programme contributed to this project.
Edit
A recent EMBO workshop brought together researchers who are expanding our understanding of how layers of genetic and epigenetic regulation underlie critical brain functions.
EditJoin us to shape EMBL AI, a new EMBL-wide initiative that aims to exploit the full potential of AI-based approaches to advance scientific discovery.The European Molecular Biology Laboratory (EMBL) has long been a pioneer in developing and applying Artificial Intelligence (AI) to advance research in...
Closes on 29th August. Posted 14th August 2026
EditHelp Shape the Future of Life Science ResearchAt the European Molecular Biology Laboratory (EMBL), we're united by a shared mission: advancing life science research for the benefit of humanity. As Europe's leading laboratory for the life sciences, EMBL brings together more than 1,900 talented people...
Closes on 6th September. Posted 14th August 2026
EditScience Education and Public Engagement TraineeEMBL’s Science Education and Public Engagement (SEPE) office leads and coordinates the institute’s science education programmes and public engagement efforts. Our activities are aimed at school science teachers, young learners between 10 and 19 years, a...
Closes on 25th August. Posted 13th August 2026
EditWith support from more than 30 countries, laboratories at six sites across Europe and thousands of scientists and engineers working together, the European Molecular Biology Laboratory (EMBL) is a powerhouse of biological expertise. EMBL is an intergovernmental organisation, headquartered in Heidelberg, and was founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies.
EMBL currently employs more than 1800 people in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton (near Cambridge), and Rome.
Publishing hundreds of research articles and hosting dozens of conferences every year, EMBL is driving visionary fundamental research and training Europe’s future scientific talent.